Table 2 Serological prevalence of HIV, HCV, syphilis and HSV-2
From: Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison
n | % (95% CI) | 2009 | 2011 | p-valuea | |
|---|---|---|---|---|---|
HIV (Ag/Ab Combo+ & Inno-Lia+) | 1/270 | 0.4% (0.1–2.1) | 0/115 (0%) | 1/155 (0.7%) | 1 |
Syphilis (ELISA+ & TPHA+ & RPR+) | 3/271 | 1.1% (0.4–3.2) | 2/114 (1.8%) | 2/157 (1.3%) | 1 |
HSV-2 (ELISA HSV-2+) | 35/156 | 22.4% (16.6–29.6) | – | 35/156 (22.4%) | – |
HCV (EIA+ & Inno-Lia+) | 17/273 | 6.2% (3.9–9.7) | 8/116 (6.9%) | 9/157 (5.7%) | .694 |